Literature DB >> 20840332

The effect of changes in thyroxine and thyroid-stimulating hormone levels on the coagulation system.

J Debeij, S C Cannegieter, B VAN Zaane, J W A Smit, E P M Corssmit, F R Rosendaal, J A Romijn, O M Dekkers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20840332     DOI： 10.1111/j.1538-7836.2010.04054.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  4 in total

1.  Assessment of the Impact of L-Thyroxine Therapy on Bleeding Risk in Patients Receiving Vitamin K Antagonists.

Authors:  Farès Moustafa; Rémi Malhomme; Bruno Pereira; Alain Barres; Jennifer Saint-Denis; Frederic Dutheil; Marie Batisse; Jeannot Schmidt
Journal:  Clin Drug Investig       Date:  2017-10       Impact factor: 2.859

2.  Major Haemorrhage during Vitamin K Antagonist Treatment: The Influence of Thyroid Hormone Levels.

Authors:  Jan Debeij; Suzanne C Cannegieter; Bregje van Zaane; Anton P van Zanten; Frits R Rosendaal; Victor E A Gerdes; Pieter H Reitsma; Olaf M Dekkers
Journal:  Eur Thyroid J       Date:  2014-02-28

3.  Negative association between free triiodothyronine level and international normalized ratio in euthyroid subjects with acute myocardial infarction.

Authors:  Li Li; Chang-yan Guo; Jing Yang; En-zhi Jia; Tie-bing Zhu; Lian-sheng Wang; Ke-jiang Cao; Wen-zhu Ma; Zhi-jian Yang
Journal:  Acta Pharmacol Sin       Date:  2011-10-03       Impact factor: 6.150

4.  Evaluation of hemostasis in hyperthyroid cats.

Authors:  Audrey E Keebaugh; Stefanie M DeMonaco; David L Panciera; Jonathan A Abbott; Katie M Boes; Giulio Menciotti
Journal:  J Vet Intern Med       Date:  2021-09-30       Impact factor: 3.333
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.